[Linear cutaneous hypopigmentation and atrophy associated with intralesional steroid injection for carpal tunnel syndrome]

Ann Dermatol Venereol. 2020 Apr;147(4):316-317. doi: 10.1016/j.annder.2020.01.012. Epub 2020 Mar 11.

[Article in French]

Authors

P Bataille¹, J-B Monfort², F Chasset², T De Risi-Pugliese², A Barbaud², P Senet²

Affiliations

¹ Service de dermatologie et allergologie, faculté de médecine, Sorbonne université, hôpital Tenon, AP-HP, 4, rue de la Chine, 75020 Paris, France. Electronic address: pauline.bataille@aphp.fr.
² Service de dermatologie et allergologie, faculté de médecine, Sorbonne université, hôpital Tenon, AP-HP, 4, rue de la Chine, 75020 Paris, France.

PMID: 32171549
DOI: 10.1016/j.annder.2020.01.012

No abstract available

Publication types

Case Reports

MeSH terms

Atrophy
Betamethasone / administration & dosage
Betamethasone / adverse effects
Betamethasone / analogs & derivatives*
Betamethasone / therapeutic use
Carpal Tunnel Syndrome / complications
Carpal Tunnel Syndrome / drug therapy*
HIV Infections / complications
Humans
Hypopigmentation / chemically induced*
Hypopigmentation / physiopathology
Injections
Injections, Intralesional
Male
Middle Aged
Skin Diseases / chemically induced*
Skin Diseases / pathology

Substances

betamethasone-17,21-dipropionate
Betamethasone